{"url_path":"/sec/bcss-wt/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2064355/0001193125-26-224313-index.html","accession_number":"0001193125-26-224313","cik":"0002064355","ticker":"BCSS","issuer_name":"Bain Capital GSS Investment Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2064355/0001193125-26-224313-index.html","primary_entity_key":"0002064355","primary_entity_name":"Bain Capital GSS Investment Corp."},"word_count":236,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\nOn October 1, 2025, we consummated the Initial Public Offering of 46,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 6,000,000 Units, at $10.00 per Unit, generating gross proceeds of $460,000,000. The securities sold in the offering were registered under the Securities Act on registration statement on\nForm S-1\n\n(No. 333-290126).\nThe SEC declared the registration statement effective on September 29, 2025.\n\nSimultaneously with the closing of the Initial Public Offering, we consummated the sale of 900,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, in a private placement to the Sponsor, generating gross proceeds of $9,000,000.\n\nOf the gross proceeds received from the Initial Public Offering and the Private Placement, an aggregate of $460,000,000 was placed in the Trust Account. The proceeds held in the Trust Account may be invested by the trustee only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under\nRule 2a-7\nunder the Investment Company Act. The specific investments in our Trust Account may change from time to time.\n\nTransaction costs amounted to $23,835,700, consisting of $7,000,000 of cash underwriting fee (net of $1,000,000 underwriters’ reimbursement), $16,100,000 of deferred underwriting fee, and $735,700 of other offering costs."}